Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Dharmaraj Durai
Observed name:
Durai, Dharmaraj
Institutions:
Cardiff and Vale University Health Board,
University Hospital of Wales
Observed institutions:
Cardiff and Vale University Health Board,
University Hospital of Wales,
Glangwili General Hospital
OpenAlex ID:
A5113879834
A biomarker-stratified comparison of top-down versus accelerated step-up treatment strategies for patients with newly diagnosed Crohn's disease (PROFILE): a multicentre, open-label randomised controlled trial
2024
·
Nurulamin M Noor
, James C Lee
, et al.
·
The Lancet. Gastroenterology & hepatology
·
336
PDF
The Ussing chamber system for measuring intestinal permeability in health and disease
2019
·
Amanda Thomson
, Kathryn Smart
, et al.
·
BMC Gastroenterology
·
148
PDF
Biologic Therapy for Inflammatory Bowel Disease: Real-World Comparative Effectiveness and Impact of Drug Sequencing in 13 222 Patients within the UK IBD BioResource
2023
·
Christina Kapizioni
, Rofaida Desoki
, et al.
·
Journal of Crohn s and Colitis
·
142
PDF
Withdrawal of infliximab or concomitant immunosuppressant therapy in patients with Crohn's disease on combination therapy (SPARE): a multicentre, open-label, randomised controlled trial
2023
·
Edouard Louis
, Matthieu Resche-Rigon
, et al.
·
The Lancet. Gastroenterology & hepatology
·
114
Development and validation of the Gastrointestinal Endoscopy Satisfaction Questionnaire (GESQ)
2015
·
Hayley Hutchings
, Wai-Yee Cheung
, et al.
·
Endoscopy
·
46
Epstein-Barr Virus-Positive Mucocutaneous Ulcers Complicate Colitis Caused by Immune Checkpoint Regulator Therapy and Associate With Colon Perforation
2019
·
Matthew R. Pugh
, Gareth D. Leopold
, et al.
·
Clinical Gastroenterology and Hepatology
·
25
Regression of primary high-grade gastric B-cell lymphoma following Helicobacter pylori eradication
2001
·
Imroz Salam
, Dharmaraj Durai
, et al.
·
European Journal of Gastroenterology & Hepatology
·
22
Implications for sequencing of biologic therapy and choice of second anti‐TNF in patients with inflammatory bowel disease: results from the IMmunogenicity to Second Anti‐TNF therapy ( IMSAT ) therapeutic drug monitoring study
2022
·
Neil Chanchlani
, Simeng Lin
, et al.
·
Alimentary Pharmacology & Therapeutics
·
21
PDF
Multiple venous malformations in the left colon and rectum: a long-standing case managed conservatively and an update of current literature
2019
·
Sashiananthan Ganesananthan
, Jonathan Barlow
, et al.
·
BMJ Case Reports
·
21
Zinc in denture adhesive: a rare cause of copper deficiency in a patient on home parenteral nutrition
2015
·
Rakesh Prasad
, Barney Hawthorne
, et al.
·
BMJ Case Reports
·
15
PDF
Psychometric development of the Gastrointestinal Symptom Rating Questionnaire (GSRQ) demonstrated good validity
2015
·
Hayley A. Hutchings
, Wai-Yee Cheung
, et al.
·
Journal of Clinical Epidemiology
·
14
Successful development and testing of a Method for Aggregating The Reporting of Interventions in Complex Studies (MATRICS)
2015
·
Hayley A. Hutchings
, Kymberley Thorne
, et al.
·
Journal of Clinical Epidemiology
·
8
Clinical value and cost saving of therapeutic drug monitoring of infliximab in adult patients with inflammatory bowel disease
2020
·
Sashiananthan Ganesananthan
, Dharmaraj Durai
·
Clinical Medicine
·
4
PDF
What Is the Clinical Effectiveness of Endoscopy Undertaken By Nurses? Multi-Institution Nurse Endoscopy Trial (MINuET) - ISRCTN 82765705
2005
·
Dharmaraj Durai
, John Williams
, et al.
·
Gastrointestinal Endoscopy
·
4
Magnetic resonance imaging-based simplified MaRIA scores are associated with future surgery in Crohn’s disease, but modest correlation with ileo-colonoscopic inflammation limits their utility in clinical trials: results from the PROFILE trial
2026
·
Megha Bhandari
, Mohmmed Tauseef Sharip
, et al.
·
Journal of Crohn s and Colitis
·
3
Long-term outcomes of top-down therapy versus a conventional step-up strategy in adults newly diagnosed with Crohn's disease: 5-year follow-up of the PROFILE trial
2026
·
Nurulamin M Noor
, Mohmmed Tauseef Sharip
, et al.
·
The Lancet. Gastroenterology & hepatology
·
2
Mirikizumab is Equally Effective in Ustekinumab-Exposed and Ustekinumab-Naïve Patients with UC: A Multicentre Real-World Cohort
2026
·
Mohmmed Tauseef Sharip
, Dharmaraj Durai
, et al.
·
Crohn s & Colitis 360
·
2
Development and validation of the Gastrointestinal Endoscopy Satisfaction Questionnaire (GESQ)
2016
·
Hayley Hutchings
, Wai-Yee Cheung
, et al.
·
Endoscopy
·
1
Tu1858: MIRIKIZUMAB IS EQUALLY EFFECTIVE IN USTEKINUMAB-EXPOSED AND USTEKINUMAB-NAÏVE PATIENTS WITH UC: A MULTICENTRE REAL-WORLD COHORT.
2025
·
Mohmmed Tauseef Sharip
, Dharmaraj Durai
, et al.
·
Gastroenterology
O27 BMJ Open Gastroenterology best clinical science abstract: endoscopic outcomes from PROFILE: a multi-centre, randomised, open-label, biomarker-stratified clinical trial of treatment strategies for patients with newly-diagnosed Crohn’s disease
2024
·
Nuru Noor
, James Lee
, et al.
·
Gut
986 Endoscopic Outcomes With Early Treatment in Newlydiagnosed Crohn's Disease: Evidence From Profile, a Multicentre, Randomized, Open-label, Biomarker-stratified Clinical Trial
2024
·
Nurulamin Noor
, James Lee
, et al.
·
Gastroenterology
Modern Insights into the Aetiology of Inflammatory Bowel Disease
2018
·
Dharmaraj Durai
, A. Barney Hawthorne
·
CRC Press eBooks
Show more works
View as search
Works count:
27
Citation count:
1,264
H-index:
12
I10-index:
12
Year
Topic
Type